View of Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes

Return to Article Details Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes Download Download PDF